MBC101: The HER2-Low Show
Essential Knowledge, Entities of Cancer, MBC Imaging and Profiling, Novel Treatments, MBC Patients, Medical Community, Precision Oncology, MBC Stories, Clinical Research, Challenges and Barriers Our MBClife Essential Knowledge, Entities of Cancer, MBC Imaging and Profiling, Novel Treatments, MBC Patients, Medical Community, Precision Oncology, MBC Stories, Clinical Research, Challenges and Barriers Our MBClife

MBC101: The HER2-Low Show

The DESTINY-Breast04 trial at ASCO 2022 introduced many people to the term “HER2-low.” But how do you know if you’re HER2-low? In this episode, with the help a breast pathologist and a clinical oncologist we dive into this subtype and what it means to us.

Read More